encainide has been researched along with Recrudescence in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bounhoure, JP; Calazel, J; Cassagneau, B; Marin, T; Massabuau, P; Miquel, JP; Narula, OS; Puel, J | 1 |
| Harrison, DC; Mason, J; Sami, M; Winkle, R | 1 |
| Mason, JW; Oyer, PE; Stinson, EB; Winkle, RA | 1 |
| Grey, E; Silverman, DI | 1 |
| Estes, NA; Manolis, AS; Weintraub, AR | 1 |
| Akhtar, M; Dougherty, AH; Jazayeri, M; Naccarelli, GV; Niazi, I; Rinkenberger, R; Tchou, P | 1 |
| Koskinen, PJ; Liisanantti, RK; Mäkynen, PJ; Saaristo, TE | 1 |
3 trial(s) available for encainide and Recrudescence
| Article | Year |
|---|---|
[Electrophysiological effects of encainide in man].
Topics: Administration, Oral; Adult; Aged; Anilides; Anti-Arrhythmia Agents; Atrioventricular Node; Cardiac Catheterization; Clinical Trials as Topic; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiology; Encainide; Female; Humans; Male; Middle Aged; Recurrence; Sinoatrial Node; Tachycardia; Time Factors | 1984 |
Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunction. The Encainide-Ventricular Tachycardia Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anilides; Clinical Trials as Topic; Electrophysiology; Encainide; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Prospective Studies; Recurrence; Tachycardia | 1988 |
Comparison of encainide and quinidine for supraventricular tachyarrhythmias.
Topics: Administration, Oral; Adult; Aged; Anilides; Anti-Arrhythmia Agents; Clinical Trials as Topic; Encainide; Female; Humans; Male; Middle Aged; Quinidine; Random Allocation; Recurrence; Tachycardia, Supraventricular | 1988 |
5 other study(ies) available for encainide and Recrudescence
| Article | Year |
|---|---|
Encainide: a new and potent antiarrhythmic agent.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Bundle of His; Dogs; Dose-Response Relationship, Drug; Electrophysiology; Encainide; Hemodynamics; Humans; Kinetics; Male; Purkinje Fibers; Quinidine; Recurrence | 1980 |
Mechanisms of ventricular tachycardia: wide, complex ignorance.
Topics: Anilides; Anti-Arrhythmia Agents; Chronic Disease; Electrophysiology; Encainide; Humans; Myocardial Infarction; Recurrence; Tachycardia | 1981 |
Efficacy of type 1C antiarrhythmic agents for treatment of resistant atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Encainide; Female; Flecainide; Heart Rate; Humans; Male; Middle Aged; Procainamide; Propafenone; Quinidine; Recurrence; Retrospective Studies | 1993 |
Electrophysiologic and electrocardiographic effects, efficacy and safety of encainide in malignant ventricular arrhythmias associated with coronary artery disease.
Topics: Aged; Aged, 80 and over; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Electrocardiography; Electrophysiology; Encainide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence | 1990 |
Role of adrenergic stimulation by isoproterenol in reversal of effects of encainide in supraventricular tachycardia.
Topics: Administration, Oral; Adult; Anilides; Anti-Arrhythmia Agents; Electrophysiology; Encainide; Female; Follow-Up Studies; Heart Conduction System; Humans; Isoproterenol; Male; Middle Aged; Recurrence; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome | 1988 |